C(1) inhibitor in canine intravascular hemolysis (C(1)INCH): study protocol for a randomized controlled trial

BACKGROUND: Immune-mediated hemolytic anemia (IMHA) is a common disease that affects all breeds of dogs and is associated with significant morbidity and mortality. Intravascular hemolysis of erythrocytes in IMHA is caused by complement activation and is often fatal. No current treatments target comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggs, Robert, Behling-Kelly, Erica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937664/
https://www.ncbi.nlm.nih.gov/pubmed/31888626
http://dx.doi.org/10.1186/s12917-019-2220-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937664/
https://www.ncbi.nlm.nih.gov/pubmed/31888626
http://dx.doi.org/10.1186/s12917-019-2220-2

Ejemplares similares